ClinicalTrials.govpublic full text
Melphalan, Arsenic Trioxide, and Ascorbic Acid in Treating Patients With Relapsed or Refractory Multiple Myeloma
stage ii multiple myeloma, stage iii multiple myeloma, refractory plasma cell neoplasm, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 830369
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.